Does tirzepatide (a dual GIP and GLP-1 receptor agonist) increase the risk of seizures?
23 These symptoms can be severe in some patients, resulting in a pause of dose escalation, and if intolerable GI symptoms continue, a dose adjustment to the previous lower dose or a switch to an alternative GLP-1 RA should be considered
Comprehensive Usage Plans: 3, 6, and 12-Month Metabolic Support Strategies The 3-Month Foundation Program The initial three-month period with ReadyRx - GLP-1 represents the foundation phase of metabolic support, focusing on establishing consistent routines and allowing the body to adapt to enhanced GLP-1 pathway activation
Investigation of a UK biobank cohort reveals causal associations of self-reported walking pace with telomere length
For women 40+: 0.51 lb per week and it fluctuates more due to hormonal cycles, water retention, and cortisol sensitivity